Nordea Investment Management
NKTR icon

Nordea Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Nordea Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,124
Closed -$578K – 990
2021
Q3 		$578K Hold
2,124
– – ﹤0.01% 903
2021
Q2 		$547K Hold
2,124
– – ﹤0.01% 912
2021
Q1 		$633K Buy
2,124
+45
+2% +$14K ﹤0.01% 860
2020
Q4 		$530K Buy
2,079
+178
+9% +$46K ﹤0.01% 853
2020
Q3 		$478K Sell
1,901
-1,901
-50% -$598K ﹤0.01% 826
2020
Q2 		$1.29M Buy
3,802
+1,903
+100% +$594K ﹤0.01% 765
2020
Q1 		$504K Sell
1,899
-9
-0.5% -$2.78K ﹤0.01% 794
2019
Q4 		$605K Sell
1,908
-453
-19% -$131K ﹤0.01% 812
2019
Q3 		$646K Hold
2,361
– – ﹤0.01% 805
2019
Q2 		$1.26M Buy
2,361
+437
+23% +$219K ﹤0.01% 736
2019
Q1 		$971K Buy
1,924
+1,428
+288% +$846K ﹤0.01% 988
2018
Q4 		$245K Hold
496
– – ﹤0.01% 1131
2018
Q3 		$453K Buy
496
+11
+2% +$9.39K ﹤0.01% 1137
2018
Q2 		$355K Buy
485
+376
+345% +$434K ﹤0.01% 968
2018
Q1 		$173K Buy
+109
New +$140K ﹤0.01% 1045

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Nordea Investment Management's NKTR Position: Q4 2021 in Review

Nordea Investment Management sold out of Nektar Therapeutics (NKTR) in Q4 2021, closing a stake of 2,124 shares — an estimated $578K sold.

Nordea Investment Management first reported a position in NKTR in Q1 2018 and held it in 15 quarters. The position peaked at $1.29M in Q2 2020. 240 funds tracked by Wall St. Rank hold NKTR as of Q4 2021.

  • Nordea Investment Management reported no remaining Nektar Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Nordea Investment Management sold 2,124 Nektar Therapeutics shares in Q4 2021, an estimated $578K.
  • Nordea Investment Management first reported a position in Nektar Therapeutics in Q1 2018 and held it in 15 quarters.
  • Nordea Investment Management's Nektar Therapeutics position peaked at $1.29M in Q2 2020.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2021.

Based on Nordea Investment Management's 13F filing for Q4 2021, filed 20 Jan 2022.